Learning Objectives:

1.  Learn about the background and controversy of fluoroquinolone use in common Pediatric Oncology conditions. 

2.  Discuss the potential risks and benefits of fluoroquinolone use in neutropenic pediatric oncology patients. 

3.  Describe the safety profile and antimicrobial resistance data of fluoroquinolone. 

Session date: 
11/04/2024 - 12:00pm to 1:00pm CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
John Flores, PGY-8